Why the study?
Is outpatient therapy with low-molecular-weight heparin feasible and safe for patients with deep-vein thrombosis or pulmonary embolism?
Population
Patients with deep-vein thrombosis or pulmonary embolism
Design
Review
Authors
Loading...
Outpatient LMWH may be feasible for selected DVT/PE patients; leaves open standardization of eligibility criteria across institutions.
Is outpatient therapy with low-molecular-weight heparin feasible and safe for patients with deep-vein thrombosis or pulmonary embolism?
Outpatient treatment of DVT and PE using low-molecular-weight heparin is feasible for a significant proportion of patients, though eligibility varies by institution.
Philip S. Wells (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: